The maker of the drug Humira will pay $ 24 million to settle a California lawsuit that alleged it violated the state;s insurance fraud law By The Associated Press August 7, 2020, 1:55 AM 1 min read OAKLAND, Calif. — The maker of the drug Humira will pay $ 24 million to settle a California… Read More »
FDA Approves Abrilada (adalimumab-afzb), a Biosimilar to Humira Print this page November 18, 2019 – Pfizer Inc. (NYSE: PFE) today announced the United States (U.S.) Food and Drug Administration (FDA) has approved Abrilada™ (adalimumab-afzb), as a biosimilar to Humira® (adalimumab),1 for the treatment of certain patients with rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing… Read More »
FDA Approves Hadlima (adalimumab-bwwd), a Biosimilar to Humira Print this page INCHEON, Korea – July 24, 2019 – Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved Hadlima (adalimumab-bwwd), a biosimilar referencing Humira (adalimumab)i, for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult… Read More »